http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4693245-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75be6095b61e431ef97cd7604b1a9122
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-3213
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00736
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 1985-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4b199864e52c69c31b562d01942335c
publicationDate 1987-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4693245-A
titleOfInvention Nucleus splitter
abstract A device for fragmentation of the nucleus of an eye lens, in vivo, including a working tip adapted to be passed through a limbal incision in the eye and beneath the nucleus of the lens, in vivo, and includes a hollow tubular portion for guiding an elongated member, a platform portion extending from the hollow tubular portion and one or more points or tines at the extreme end of the platform portion all adapted for immobilizing the nucleus while the elongated member is advanced into and removed from the nucleus, guided by the hollow tubular portion, causing its fragmentation. A modified syringe embodiment is described in which the elongated splitting member is coupled with and manipulated by means of a syringe plunger.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357620-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012191114-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406490-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9320651-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5222960-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723803-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015342781-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045309-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9681946-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021361480-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11382736-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10478334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9877825-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10517758-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015230981-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446138-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10080648-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10028824-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2009352530-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4950272-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10932951-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0356372-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0356372-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11076948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463536-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5634884-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925040-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016235587-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413188-B2
priorityDate 1985-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-1677209-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300

Total number of triples: 49.